Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (AML)

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Hardikkumar Jetani, Almudena Navarro-Bailón, Marius Maucher, Silke Frenz, Christina Mathilde Verbruggen, Ana Yeguas, María-Belén Vidriales, Marcos González, Judit Rial Saborido, Sabrina Kraus, Katrin Mestermann, Simone Thomas, Halvard Bonig, Maik Luu, Razieh Monjezi, Dimitrios Mougiakakos, Markus Sauer, Hermann Einsele, Michael Hudecek

Journal title: Blood

Journal publisher: American Society of Hematology

Published year: 2021

DOI identifier: 10.1182/blood.2020009192

ISSN: 0006-4971